Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis. - Ku JH; Qian L; Sy LS; Ackerson BK; Rayens E; Luo Y; Qiu S; Xu L; Lee GS; Modha PP; Hoke CF; Joe C; et al. (Open forum infectious diseases, 2026)